Professor Didier Raoult is the director of the IHU – Daniel Cole / AP / SIPA
The IHU Mediterranean Infection of Marseille “Will continue to treat (his) patients with the most suitable treatments”, reacted on Wednesday the institute directed by the professor
Didier Raoult, after the repeal of provisions authorizing hospitals to prescribe hydroxychloroquine against
Covid-19.
“We will continue to treat our patients with the treatments that we consider the most suitable in the current state of science and knowledge,” said the Marseille University Hospital Institute, which has already treated nearly 4,000 people affected by the SARS-CoV-2.
Repealed Decree
Most of them were prescribed a combination of hydroxychloroquine and azithromycin, an antibiotic. The IHU Méditerranée Infection, a world-renowned Marseille treatment and research center, thus reacted to the decree published on Wednesday, which repeals the derogations authorizing hospitals to treat patients suffering from Covid-19 with hydroxychloroquine, a derivative of chloroquine usually used against lupus and rheumatoid arthritis.
If article 19 of the decree of 11 May laying down these derogating provisions is now repealed, the freedom of doctors to prescribe is not thereby suppressed and a hospital practitioner can still prescribe and administer a drug without a marketing authorization.
